![](https://xpic.x-mol.com/20220722%2F1658458355232.jpg)
广西师范大学“药用资源化学与药物分子工程国家重点实验室”专职科研岗人员,讲师。2018年毕业于广西师范大学并获得理学博士学位。目前在美国密歇根大学进行博士后深造。迄今以第一作者身份在Nature Communications、European Journal of Medicinal Chemistry、Oncotarget和Journal of Inorganic Biochemistry等期刊发表SCI论文7篇。
代表性论文:
1. Zhang Y, Jiang Y, Gao K, Sui D, Yu P, Su M, Wei GW, Hu J. Structural insights into the elevator-type transport mechanism of a bacterial ZIP metal transporter. Nature Communications, 2023, 14: 385.
2. Yue JP#, Zhang Y#, Liang WG, Gou XW, Lee P, Liu H, Lyv WQ, Tang WJ, Yang F*, Liang H*, Wu XY*. In vivo epidermal migration requires focal adhesion targeting of ACF7. Nature Communications, 2016, 7: 11692.
3. Ma YL#, Yue JP#, Zhang Y#, Shi CZ#, Odenwald M, Liang WG, Wei Q, Goel A, Gou XW, Zhang J, Chen SY, Tang WJ, Turner JR, Yang F*, Liang H*, Qin HL*, Wu XY*. ACF7 regulates inflammatory colitis and intestinal wound response by orchestrating tight junction dynamics. Nature Communications, 2017, 8: 15375.
4. Zhang Y, Zhang ZL, Gou Y, Jiang M, Khan H, Zhou ZP*, Liang H*, Yang F*. Design an anticancer copper(II) pro-drug based on the flexible IIA subdomain of human serum albumin. Journal of Inorganic Biochemistry, 2017, 172: 1−8.
5. Gou Y#, Zhang Y#, Qi JX, Chen SF, Zhou ZP, Wu XY, Liang H*, Yang F*. Developing an anticancer copper(II) pro-drug based on the nature of cancer cell and human serum albumin carrier IIA subdomain: mouse model of breast cancer. Oncotarget, 2016, 7: 67004−67019.
6. Zhang Y, Lee P, Liang SC, Zhou ZP, Wu XY, Yang F*, Liang H*. Structural basis of non-steroidal anti-inflammatory drug diclofenac binding to human serum albumin. Chemical Biology & Drug Design, 2015, 86: 1178−1184.
7. Zhang Y, Ho A, Yue JP, Kong LL, Zhou ZP, Wu XY, Yang F*, Liang H*. Structural basis and anticancer properties of ruthenium-based drug complexed with human serum albumin. European Journal of Medicinal Chemistry, 2014, 86: 449−455.